Showing results (81-90 of 92) with videos related to
Sort By:
Pageof 10
International Journal of Molecular Sciences|July 29, 2023
Structure-Based Discovery of Receptor Activator of Nuclear Factor-κB Ligand (RANKL)-Induced Osteoclastogenesis InhibitorsVagelis Rinotas, Fotini Liepouri, Maria-Dimitra Ouzouni, et al.Chembiochem : a European Journal of Chemical Biology|December 15, 2010
Designed spiro-bicyclic analogues targeting the ribosomal decoding centerThomas Cottin, Constantina Pyrkotis, Christos I Stathakis, et al.Cancer Immunology, Immunotherapy : CII|June 22, 2019
Editing the immunopeptidome of melanoma cells using a potent inhibitor of endoplasmic reticulum aminopeptidase 1 (ERAP1)Despoina Koumantou, Eilon Barnea, Adrian Martin-Esteban, et al.The Journal of Biological Chemistry|March 19, 2020
A systematic re-examination of processing of MHCI-bound antigenic peptide precursors by endoplasmic reticulum aminopeptidase 1George Mavridis, Richa Arya, Alexander Domnick, et al.Chemmedchem|May 28, 2026
Design and Synthesis of Pyrimidino[4,5-d]Pyrimidine-Based Compounds as Potent B-RAF V600E InhibitorsEleftheria A Georgiou, Kalliopi Christopoulou, Amalia D Kalampaliki, et al.International Journal of Molecular Sciences|January 8, 2023
The Inhibitory Properties of a Novel, Selective LMTK3 Kinase InhibitorAlessandro Agnarelli, Andrea Lauer Betrán, Athanasios Papakyriakou, et al.Journal of Medicinal Chemistry|September 9, 2016
Optimization and Structure-Activity Relationships of Phosphinic Pseudotripeptide Inhibitors of Aminopeptidases That Generate Antigenic PeptidesParaskevi Kokkala, Anastasia Mpakali, Francois-Xavier Mauvais, et al.Journal of Immunology (Baltimore, Md. : 1950)|July 28, 2012
A common single nucleotide polymorphism in endoplasmic reticulum aminopeptidase 2 induces a specificity switch that leads to altered antigen processingIrini Evnouchidou, James Birtley, Sergey Seregin, et al.The Journal of Biological Chemistry|October 18, 2019
Human leukocyte antigen (HLA) class II peptide flanking residues tune the immunogenicity of a human tumor-derived epitopeBruce J MacLachlan, Garry Dolton, Athanasios Papakyriakou, et al.Archiv Der Pharmazie|August 28, 2014
Rationally designed less toxic SPD-304 analogs and preliminary evaluation of their TNF inhibitory effectsPolyxeni Alexiou, Athanasios Papakyriakou, Evangelos Ntougkos, et al.Pageof 10